IRIS Accounts Production v26.2.0.496 08751132 director 1.1.25 31.12.25 31.12.25 false true false false false true false iso4217:GBPiso4217:USDiso4217:EURxbrli:sharesxbrli:pureutr:tonnesutr:kWh087511322024-12-31087511322025-12-31087511322025-01-012025-12-31087511322023-10-31087511322023-11-012024-12-31087511322024-12-3108751132ns15:EnglandWales2025-01-012025-12-3108751132ns14:PoundSterling2025-01-012025-12-3108751132ns10:Director12025-01-012025-12-3108751132ns10:PrivateLimitedCompanyLtd2025-01-012025-12-3108751132ns10:SmallEntities2025-01-012025-12-3108751132ns10:AuditExempt-NoAccountantsReport2025-01-012025-12-3108751132ns10:SmallCompaniesRegimeForDirectorsReport2025-01-012025-12-3108751132ns10:SmallCompaniesRegimeForAccounts2025-01-012025-12-3108751132ns10:FullAccounts2025-01-012025-12-310875113212025-01-012025-12-3108751132ns10:CompanySecretary12025-01-012025-12-3108751132ns10:RegisteredOffice2025-01-012025-12-3108751132ns5:CurrentFinancialInstruments2025-12-3108751132ns5:CurrentFinancialInstruments2024-12-3108751132ns5:Non-currentFinancialInstruments2025-12-3108751132ns5:Non-currentFinancialInstruments2024-12-3108751132ns5:ShareCapital2025-12-3108751132ns5:ShareCapital2024-12-3108751132ns5:RetainedEarningsAccumulatedLosses2025-12-3108751132ns5:RetainedEarningsAccumulatedLosses2024-12-3108751132ns5:IntangibleAssetsOtherThanGoodwill2025-01-012025-12-3108751132ns5:PlantMachinery2025-01-012025-12-3108751132ns5:ComputerEquipment2025-01-012025-12-3108751132ns5:PatentsTrademarksLicencesConcessionsSimilar2024-12-3108751132ns5:PatentsTrademarksLicencesConcessionsSimilar2025-12-3108751132ns5:PatentsTrademarksLicencesConcessionsSimilar2024-12-3108751132ns5:PlantMachinery2024-12-3108751132ns5:ComputerEquipment2024-12-3108751132ns5:PlantMachinery2025-12-3108751132ns5:ComputerEquipment2025-12-3108751132ns5:PlantMachinery2024-12-3108751132ns5:ComputerEquipment2024-12-3108751132ns5:WithinOneYearns5:CurrentFinancialInstruments2025-12-3108751132ns5:WithinOneYearns5:CurrentFinancialInstruments2024-12-3108751132ns5:Non-currentFinancialInstrumentsns5:BetweenOneTwoYears2025-12-3108751132ns5:Non-currentFinancialInstrumentsns5:BetweenOneTwoYears2024-12-31
REGISTERED NUMBER: 08751132 (England and Wales)










Speciality Medical Devices Limited

Unaudited Financial Statements

for the Year Ended 31 December 2025






Speciality Medical Devices Limited (Registered number: 08751132)






Contents of the Financial Statements
for the Year Ended 31 December 2025




Page

Company Information 1

Balance Sheet 2

Notes to the Financial Statements 4


Speciality Medical Devices Limited

Company Information
for the Year Ended 31 December 2025







DIRECTOR: Mr A E Micklethwaite





SECRETARY: Mrs. A Micklethwaite





REGISTERED OFFICE: 2 Heap Bridge
Bury
BL9 7HR





REGISTERED NUMBER: 08751132 (England and Wales)





ACCOUNTANTS: RAA Thompson Jones Business Solutions Ltd
2 Heap Bridge
Bury
Lancashire
BL9 7HR

Speciality Medical Devices Limited (Registered number: 08751132)

Balance Sheet
31 December 2025

2025 2024
Notes £    £   
Fixed assets
Intangible assets 5 - -
Tangible assets 6 817 221
817 221

Current assets
Debtors 7 10,767 10,767
Cash at bank 2,401 3,866
13,168 14,633
Creditors
Amounts falling due within one year 8 (3,810 ) (7,454 )
Net current assets 9,358 7,179
Total assets less current liabilities 10,175 7,400

Creditors
Amounts falling due after more than one
year

9

(7,868

)

(8,422

)
Net assets/(liabilities) 2,307 (1,022 )

Capital and reserves
Called up share capital 130 130
Retained earnings 2,177 (1,152 )
2,307 (1,022 )

Speciality Medical Devices Limited (Registered number: 08751132)

Balance Sheet - continued
31 December 2025


The company is entitled to exemption from audit under Section 477 of the Companies Act 2006 for the year ended 31 December 2025.

The members have not required the company to obtain an audit of its financial statements for the year ended 31 December 2025 in accordance with Section 476 of the Companies Act 2006.

The director acknowledges his responsibilities for:
(a)ensuring that the company keeps accounting records which comply with Sections 386 and 387 of the Companies Act 2006 and
(b)preparing financial statements which give a true and fair view of the state of affairs of the company as at the end of each financial year and of its profit or loss for each financial year in accordance with the requirements of Sections 394 and 395 and which otherwise comply with the requirements of the Companies Act 2006 relating to financial statements, so far as applicable to the company.

The financial statements have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies regime.

In accordance with Section 444 of the Companies Act 2006, the Profit and Loss Account and Statement of Retained Earnings has not been delivered.

The financial statements were approved by the director and authorised for issue on 24 August 2026 and were signed by:





Mr A E Micklethwaite - Director


Speciality Medical Devices Limited (Registered number: 08751132)

Notes to the Financial Statements
for the Year Ended 31 December 2025

1. STATUTORY INFORMATION

The company is a private company limited by share capital, incorporated in England & Wales.

The address of its registered office is:
2 Heap Bridge
Bury
United Kingdom
BL9 7HR

2. STATEMENT OF COMPLIANCE

These financial statements have been prepared in accordance with Financial Reporting Standard 102 "The Financial Reporting Standard applicable in the UK and Republic of Ireland" including the provisions of Section 1A "Small Entities" and the Companies Act 2006.

3. ACCOUNTING POLICIES

SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES AND KEY ACCOUNTING ESTIMATES
The principal accounting policies applied in the preparation of these financial statements are set out below.These policies have been consistently applied to all the years presented, unless otherwise stated.

BASIS OF PREPARATION
These financial statements have been prepared using the historical cost convention except that as disclosed in the accounting policies certain items are shown at fair value.

CASH AND CASH EQUIVALENTS
Cash and cash equivalents comprise cash on hand and call deposits, and other short-term highly liquid investments that are readily convertible to a known amount of cash and are subject to an insignificant risk of change in value

INTANGIBLE ASSETS
Separately acquired trademarks and licences are shown at historical cost.

Trademarks, licences (including software) and customer-related intangible assets acquired in a business combination are recognised at fair value at the acquisition date.

Trademarks, licences and customer-related intangible assets have a finite useful life and are carried at cost less accumulated amortisation and any accumulated impairment losses.

AMORTISATION
Amortisation is provided on intangible assets so as to write off the cost, less any estimated residual value, over their useful life as follows:

Asset class Amortisation method and rate - Patents 20% straight line

TANGIBLE FIXED ASSETS
Depreciation is provided at the following annual rates in order to write off the cost less estimated residual value of each asset over its estimated useful life.
Plant and machinery - 25% on cost
Office equipment - 25% on reducing balance


Speciality Medical Devices Limited (Registered number: 08751132)

Notes to the Financial Statements - continued
for the Year Ended 31 December 2025

3. ACCOUNTING POLICIES - continued
TAXATION
Taxation for the year comprises current and deferred tax. Tax is recognised in the Profit and Loss Account and Statement of Retained Earnings, except to the extent that it relates to items recognised in other comprehensive income or directly in equity.

Current or deferred taxation assets and liabilities are not discounted.

Current tax is recognised at the amount of tax payable using the tax rates and laws that have been enacted or substantively enacted by the balance sheet date.

DEFERRED TAX
Deferred tax is recognised in respect of all timing differences that have originated but not reversed at the balance sheet date.

Timing differences arise from the inclusion of income and expenses in tax assessments in periods different from those in which they are recognised in financial statements. Deferred tax is measured using tax rates and laws that have been enacted or substantively enacted by the year end and that are expected to apply to the reversal of the timing difference.

Unrelieved tax losses and other deferred tax assets are recognised only to the extent that it is probable that they will be recovered against the reversal of deferred tax liabilities or other future taxable profits.

TRADE DEBTORS
Trade debtors are amounts due from customers for merchandise sold or services performed in the ordinary course of business.

Trade debtors are recognised initially at the transaction price. They are subsequently measured at amortised cost using the effective interest method, less provision for impairment. A provision for the impairment of trade debtors is established when there is objective evidence that the company will not be able to collect all amounts due according to the original terms of the receivables.

TRADE CREDITORS
Trade creditors are obligations to pay for goods or services that have been acquired in the ordinary course of business from suppliers. Accounts payable are classified as current liabilities if the company does not have an unconditional right, at the end of the reporting period, to defer settlement of the creditor for at least twelve months after the reporting date. If there is an unconditional right to defer settlement for at least twelve months after the reporting date, they are presented as non-current liabilities.

Trade creditors are recognised initially at the transaction price and subsequently measured at amortised cost using the effective interest method.

BORROWINGS
Interest-bearing borrowings are initially recorded at fair value, net of transaction costs. Interest-bearing borrowings are subsequently carried at amortised cost, with the difference between the proceeds, net of transaction costs, and the amount due on redemption being recognised as a charge to the profit and loss account over the period of the relevant borrowing.

Interest expense is recognised on the basis of the effective interest method and is included in interest payable and similar charges.

Borrowings are classified as current liabilities unless the company has an unconditional right to defer settlement of the liability for at least twelve months after the reporting date.

Speciality Medical Devices Limited (Registered number: 08751132)

Notes to the Financial Statements - continued
for the Year Ended 31 December 2025

3. ACCOUNTING POLICIES - continued

SHARE CAPITAL
Ordinary shares are classified as equity. Equity instruments are measured at the fair value of the cash or other resources received or receivable, net of the direct costs of issuing the equity instruments. If payment is deferred and the time value of money is material, the initial measurement is on a present value basis.

4. EMPLOYEES AND DIRECTORS

The average number of employees during the year was 1 (2024 - 1 ) .

5. INTANGIBLE FIXED ASSETS
Patents
and
licences
£   
COST
At 1 January 2025
and 31 December 2025 11,101
AMORTISATION
At 1 January 2025
and 31 December 2025 11,101
NET BOOK VALUE
At 31 December 2025 -
At 31 December 2024 -

6. TANGIBLE FIXED ASSETS
Plant and Office
machinery equipment Totals
£    £    £   
COST
At 1 January 2025 3,000 1,284 4,284
Additions - 710 710
At 31 December 2025 3,000 1,994 4,994
DEPRECIATION
At 1 January 2025 3,000 1,063 4,063
Charge for year - 114 114
At 31 December 2025 3,000 1,177 4,177
NET BOOK VALUE
At 31 December 2025 - 817 817
At 31 December 2024 - 221 221

Speciality Medical Devices Limited (Registered number: 08751132)

Notes to the Financial Statements - continued
for the Year Ended 31 December 2025

7. DEBTORS: AMOUNTS FALLING DUE WITHIN ONE YEAR
2025 2024
£    £   
Other debtors 2,717 2,717
Directors' current accounts 8,050 8,050
10,767 10,767

8. CREDITORS: AMOUNTS FALLING DUE WITHIN ONE YEAR
2025 2024
£    £   
Bank loans and overdrafts (see note 10) 2,296 4,043
Trade creditors - 94
Corporation tax 728 2,717
Accrued expenses 786 600
3,810 7,454

9. CREDITORS: AMOUNTS FALLING DUE AFTER MORE THAN ONE YEAR
2025 2024
£    £   
Bank loans (see note 10) 7,868 8,422

10. LOANS

An analysis of the maturity of loans is given below:

2025 2024
£    £   
Amounts falling due within one year or on demand:
Bank loans 2,296 4,043

Amounts falling due between one and two years:
Bank loans - 1-2 years 7,868 8,422